Skip to content
Featured ButtonFraud Hotline
Search
4062 results found for *.

  1. Chairman Rick Scott, Sen. Mark Kelly Lead Bipartisan Resolution Designating March 5th as National Slam the Scam Day

    WASHINGTON D C Today Chairman Rick Scott and Senator Mark Kelly announced the introduction of their resolution to designate March 5th as National Slam the Scam Day to raise...

  2. Chairman Rick Scott’s CLEAR LABELS Act Garners Bicameral Support with Rep. McCormick in the U.S. House

    WASHINGTON D C Today Chairman Rick Scott s bipartisan Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings CLEAR LABELS Act received...

  3. Chairman Scott, Ranking Member Gillibrand Press America’s Pharmacies on U.S. Drug Supply Chain and Country-of-Origin Labeling for Foreign-Made Drugs

    WASHINGTON D C Today Chairman Rick Scott and Ranking Member Kirsten Gillibrand of the U S Senate Special Committee on Aging sent a letter to the chief executive officers of CVS...

  4. Chairman Rick Scott Addresses Regulatory Hurdles Delaying Rare Disease Treatments and Limiting Patient Access to Innovation

    WASHINGTON D C Today Chairman Rick Scott led a hearing entitled From Regulator to Roadblock How FDA Bureaucracy Stifles Innovation This hearing examined how regulatory processes...

  5. El presidente del Comité Rick Scott aborda los obstáculos regulatorios que retrasan los tratamientos de enfermedades raras y limitan el acceso de los pacientes a la innovación

    WASHINGTON D C El Senador Rick Scott presidente del Comité Especial del Senado de EE UU para asuntos de la vejez dirigió una audiencia titulada Del regulador al bloqueo Cómo la...

  6. From Regulator to Roadblock: How FDA Bureaucracy Stifles Innovation

    Date Thursday February 26th 2026 Time 09 30am Location SH 216 Open in New Window ...

  7. Chairman Scott, Ranking Member Gillibrand to Examine FDA Regulatory Processes, Rare Disease Treatment Delays, and the Need to Improve Patient Access to Innovation

    WASHINGTON D C On Thursday February 26 Chairman Rick Scott and Ranking Member Kirsten Gillibrand will convene a hearing entitled From Regulator to Roadblock How FDA Bureaucracy...

  8. El presidente del Comité Scott y la miembro de alto rango Gillibrand examinarán los procesos regulatorios de la FDA, los retrasos en el tratamiento de enfermedades raras y la necesidad de mejorar el acceso de los pacientes a la innovación

    WASHINGTON D C El Jueves 26 de Febrero el presidente del Comité Especial del Senado de EE UU para asuntos de la vejez Rick Scott y la miembro de alto rango Kirsten Gillibrand...

  9. Chairman Rick Scott Sends Letter to Secretary Hegseth on Securing Generic Drug Supply for Service Members and Veterans

    WASHINGTON D C Yesterday Chairman Rick Scott and Ranking Member Kirsten Gillibrand sent a letter to Department of War Secretary Pete Hegseth requesting information on efforts to...

  10. Chairman Rick Scott to Convene Hearing on FDA Regulatory Processes, Rare Disease Treatment Delays, and Opportunities to Improve Patient Access to Innovation

    On Thursday February 26 Chairman Rick Scott of the U S Senate Special Committee on Aging will convene a hearing entitled From Regulator to Roadblock How FDA Bureaucracy Stifles...